IM Cannabis Corp. (IMCC.CN)
CAD 2.75
(-8.33%)
CAD 2.75
(-8.33%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.84 Million CAD | -25.16% |
| 2022 | 9.16 Million CAD | -11.01% |
| 2021 | 10.29 Million USD | -1.64% |
| 2020 | 10.46 Million CAD | 166.43% |
| 2019 | 3.92 Million CAD | -6.41% |
| 2018 | 4.19 Million CAD | 49.77% |
| 2017 | 2.8 Million CAD | 0.0% |
| 2016 | - CAD | 100.0% |
| 2015 | -514.00 CAD | 90.84% |
| 2014 | -5611.00 CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | -100.0% |
| 2001 | 34.58 Thousand CAD | -68.81% |
| 2000 | 110.89 Thousand CAD | 10.89% |
| 1999 | 100 Thousand CAD | 0.0% |
| 1998 | 100 Thousand CAD | -83.33% |
| 1997 | 600 Thousand CAD | -45.45% |
| 1996 | 1.1 Million CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.77 Million CAD | 111.53% |
| 2024 Q2 | 844 Thousand CAD | -52.56% |
| 2023 Q4 | 841 Thousand CAD | -90.66% |
| 2023 FY | 6.85 Million CAD | -25.16% |
| 2023 Q2 | 3.45 Million CAD | -2.59% |
| 2023 Q3 | 9 Million CAD | 160.56% |
| 2023 Q1 | 3.54 Million CAD | 36.3% |
| 2022 Q3 | 1.95 Million CAD | -51.36% |
| 2022 Q4 | 2.6 Million CAD | 33.28% |
| 2022 Q1 | 6.57 Million CAD | 52.4% |
| 2022 Q2 | 4.01 Million CAD | -38.89% |
| 2022 FY | 9.16 Million CAD | -11.01% |
| 2021 Q3 | 1.52 Million CAD | 368.49% |
| 2021 Q2 | -568 Thousand CAD | -111.3% |
| 2021 Q1 | 5.02 Million CAD | 891.72% |
| 2021 Q4 | 4.31 Million USD | 182.69% |
| 2021 FY | 10.29 Million USD | -1.64% |
| 2020 Q4 | 507 Thousand CAD | -85.0% |
| 2020 Q3 | 3.38 Million CAD | 70.07% |
| 2020 FY | 10.46 Million CAD | 166.43% |
| 2020 Q2 | 1.98 Million CAD | -56.71% |
| 2020 Q1 | 4.59 Million CAD | 1775.91% |
| 2019 Q2 | 2.26 Million CAD | 73.89% |
| 2019 Q3 | 637 Thousand CAD | -71.86% |
| 2019 FY | 3.92 Million CAD | -6.41% |
| 2019 Q4 | -274 Thousand CAD | -143.01% |
| 2019 Q1 | 1.3 Million CAD | 324.1% |
| 2018 Q4 | 307 Thousand CAD | 5.5% |
| 2018 FY | 4.19 Million CAD | 49.77% |
| 2018 Q1 | 1.01 Million CAD | 0.0% |
| 2018 Q2 | -36 Thousand CAD | -103.56% |
| 2018 Q3 | 291 Thousand CAD | 908.33% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | 2.8 Million CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | - CAD | 100.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2015 FY | -514.00 CAD | 90.84% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2014 FY | -5611.00 CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2010 Q1 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 Q4 | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 Q1 | - CAD | -100.0% |
| 2002 FY | - CAD | -100.0% |
| 2001 Q2 | 17.82 Thousand CAD | 172.53% |
| 2001 Q3 | 7300.00 CAD | -59.05% |
| 2001 FY | 34.58 Thousand CAD | -68.81% |
| 2001 Q1 | 6541.00 CAD | -62.23% |
| 2001 Q4 | 9457.00 CAD | 29.55% |
| 2000 Q3 | 1.00 CAD | -100.0% |
| 2000 Q4 | 17.31 Thousand CAD | 1731800.0% |
| 2000 Q2 | 100 Thousand CAD | 0.0% |
| 2000 Q1 | - CAD | -100.0% |
| 2000 FY | 110.89 Thousand CAD | 10.89% |
| 1999 Q2 | 100 Thousand CAD | 200.0% |
| 1999 Q1 | -100 Thousand CAD | -200.0% |
| 1999 FY | 100 Thousand CAD | 0.0% |
| 1999 Q4 | 100 Thousand CAD | 0.0% |
| 1999 Q3 | 100 Thousand CAD | 0.0% |
| 1998 Q2 | 100 Thousand CAD | 200.0% |
| 1998 Q4 | 100 Thousand CAD | 0.0% |
| 1998 Q1 | -100 Thousand CAD | -133.33% |
| 1998 FY | 100 Thousand CAD | -83.33% |
| 1998 Q3 | 100 Thousand CAD | 0.0% |
| 1997 Q4 | 300 Thousand CAD | 50.0% |
| 1997 FY | 600 Thousand CAD | -45.45% |
| 1997 Q2 | 100 Thousand CAD | 0.0% |
| 1997 Q3 | 200 Thousand CAD | 100.0% |
| 1996 FY | 1.1 Million CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aion Therapeutic Inc. | -285.33 Thousand CAD | 3550.681% |
| Ayurcann Holdings Corp. | 8.46 Million CAD | -16.31% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -11590.116% |
| The BC Bud Corporation | 59.5 Thousand CAD | -16447.065% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -2545.018% |
| CordovaCann Corp. | 3.26 Million CAD | -201.15% |
| Christina Lake Cannabis Corp. | 3.46 Million CAD | -184.061% |
| Captor Capital Corp. | 16.93 Million CAD | 41.869% |
| City View Green Holdings Inc. | -290.73 Thousand CAD | 3486.554% |
| 1CM Inc. | 7.6 Million CAD | -29.405% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 3035.801% |
| Lobe Sciences Ltd. | 772.82 Thousand CAD | -1174.025% |
| Maple Leaf Green World Inc. | -17.85 Thousand CAD | 55247.306% |
| Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 2945.665% |
| Nextleaf Solutions Ltd. | 1.24 Million CAD | -689.283% |
| Ovation Science Inc. | -251.43 Thousand CAD | 4015.985% |
| Pharmadrug Inc. | -26.21 Thousand CAD | 37657.217% |
| Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -5924.524% |
| RAMM Pharma Corp. | -902.83 Thousand CAD | 1190.564% |
| RIV Capital Inc. | -958.27 Thousand CAD | 1127.468% |
| Revive Therapeutics Ltd. | -328.00 CAD | 3001929.268% |
| Red White & Bloom Brands Inc. | 29.48 Million CAD | 66.607% |
| SLANG Worldwide Inc. | 18.61 Million CAD | 47.12% |
| 1933 Industries Inc. | -602.75 Thousand CAD | 1733.491% |
| Red Light Holland Corp. | 2.02 Million CAD | -387.313% |
| Top Strike Resources Corp. | 2.84 Million CAD | -245.844% |
| Xebra Brands Ltd. | -367.96 Thousand CAD | 2775.805% |
| Adastra Holdings Ltd. | 7.03 Million CAD | -40.05% |